1Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden
2Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
3Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden
4Translational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
5Karolinska Institutet/AstraZeneca Integrated CardioMetabolic Center (KI/AZ IC MC), Department of Medicine, Novum, Huddinge, Sweden
6Pharmaceutical Technology & Development, AstraZeneca AB, Gothenburg, Sweden
7Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
8Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
9Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden
10Institute of Computer Science, Polish Academy of Sciences, Warsaw, Poland
© The Author(s) 2019
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
